Video

Expert Discusses Proposed Changes to USP Compounding Chapters

Author(s):

Ashley Gallagher, Editor

Amy Summers, PharmD, BCSCP, consultant at Restore Health Consulting, discusses her CPhT 2021 conference presentation regarding proposed changes to the USP <795> and <797>.

In a Pharmacy Times® interview, Amy Summers, PharmD, BCSCP, consultant at Restore Health Consulting, discussed her CPhT 2021 conference presentation regarding proposed changes to the USP <795> and <797>.

She talked about what the USP compounding chapters are, the proposed changes, and how the proposed changes to the chapters could impact the workflow of pharmacy technicians.

Related Videos
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Related Content
Drug Prices, Ozempic, Biktarvy | Image Credit: lucid_dream | stock.adobe.com
January 21st 2025

Ozempic, Biktarvy Among the Drugs Seeing List Price Increases at the Start of 2025

Ashley Gallagher, Editor
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
3D rendering of CAR T-cells | Image Credit: © Animager - stock.adobe.com
January 21st 2025

Ciltacabtagene Autoleucel Demonstrates Superior Progression-Free Survival in Patients With Relapsed, Refractory Multiple Myeloma

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Bispecific antibodies | Image Credit: © Александр Михайлюк - stock.adobe.com
January 21st 2025

KN026 and Docetaxel Show Promise as First-Line Treatment for HER2+ Metastatic Breast Cancer

Alexandra Gerlach, Associate Editor
https://mjh.sanity.studio/pharmacytimes/structure/article;f92c7f62-819f-4824-89b7-593f5761b127%2Ctemplate%3Darticle
January 21st 2025

Esketamine Receives FDA Approval for Adults With Treatment-Resistant Depression

Alexandra Gerlach, Associate Editor